A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis
Public ClinicalTrials.gov record NCT02718898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Versus Placebo in Patients With Moderate-to-Severe Genital Psoriasis
Study identification
- NCT ID
- NCT02718898
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Interventions
- Ixekizumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2016
- Primary completion
- Feb 21, 2017
- Completion
- Feb 20, 2018
- Last update posted
- Sep 15, 2019
2016 – 2018
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern California Dermatology | Santa Ana | California | 92701 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Olympian Clinical Research | Tampa | Florida | 33609 | — |
| Advanced Medical Research | Sandy Springs | Georgia | 30328 | — |
| Dawes Fretzin Clinical Research | Indianapolis | Indiana | 46256 | — |
| The South Bend Clinic | South Bend | Indiana | 46617 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Clinical Partners LLC | Johnston | Rhode Island | 02919 | — |
| Modern Research Associates PLLC | Dallas | Texas | 75231 | — |
| Menter Dermatology Research Institute | Dallas | Texas | 75246 | — |
| Pflugerville Dermatology Clinical Research Center | Pflugerville | Texas | 78660 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02718898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2019 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02718898 live on ClinicalTrials.gov.